Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Plos One
|
July 11, 2019
Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy
Carina Hage, Sabine Hoves, Mailin Ashoff, et al.
International Journal of Molecular Sciences
|
January 8, 2023
Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies
Sonia Domingos-Pereira, Karthik Sathiyanadan, Lenka Polak, et al.
Nature Cell Biology
|
June 14, 2016
Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity
Caroline Baer, Mario Leonardo Squadrito, Damya Laoui, et al.
Cell Reports
|
June 6, 2019
Molecular Profiling and Functional Analysis of Macrophage-Derived Tumor Extracellular Vesicles
Chiara Cianciaruso, Tim Beltraminelli, Florent Duval, et al.
Science Translational Medicine
|
August 12, 2021
Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models
Amaia Martinez-Usatorre, Ece Kadioglu, Gael Boivin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2012
GA201 (RG7160): a novel, humanized, glycoengineered anti-EGFR antibody with enhanced ADCC and superior in vivo efficacy compared with cetuximab
Christian A Gerdes, Valeria Gonzalez Nicolini, Sylvia Herter, et al.
Oncoimmunology
|
April 28, 2022
Tumor-associated macrophages promote intratumoral conversion of conventional CD4<sup>+</sup> T cells into regulatory T cells via PD-1 signalling
Kevin Kos, Camilla Salvagno, Max D Wellenstein, et al.
Cancers
|
June 2, 2021
Targeting CSF1R Alone or in Combination with PD1 in Experimental Glioma
Justyna M Przystal, Hannes Becker, Denis Canjuga, et al.
Mabs
|
March 18, 2016
XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer
Juergen M Schanzer, Katharina Wartha, Ekkehard Moessner, et al.
The Journal of Experimental Medicine
|
February 14, 2018
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
Sabine Hoves, Chia-Huey Ooi, Carsten Wolter, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Plos One
|
July 11, 2019
Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy
Carina Hage, Sabine Hoves, Mailin Ashoff, et al.
International Journal of Molecular Sciences
|
January 8, 2023
Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies
Sonia Domingos-Pereira, Karthik Sathiyanadan, Lenka Polak, et al.
Nature Cell Biology
|
June 14, 2016
Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity
Caroline Baer, Mario Leonardo Squadrito, Damya Laoui, et al.
Cell Reports
|
June 6, 2019
Molecular Profiling and Functional Analysis of Macrophage-Derived Tumor Extracellular Vesicles
Chiara Cianciaruso, Tim Beltraminelli, Florent Duval, et al.
Science Translational Medicine
|
August 12, 2021
Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models
Amaia Martinez-Usatorre, Ece Kadioglu, Gael Boivin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2012
GA201 (RG7160): a novel, humanized, glycoengineered anti-EGFR antibody with enhanced ADCC and superior in vivo efficacy compared with cetuximab
Christian A Gerdes, Valeria Gonzalez Nicolini, Sylvia Herter, et al.
Oncoimmunology
|
April 28, 2022
Tumor-associated macrophages promote intratumoral conversion of conventional CD4<sup>+</sup> T cells into regulatory T cells via PD-1 signalling
Kevin Kos, Camilla Salvagno, Max D Wellenstein, et al.
Cancers
|
June 2, 2021
Targeting CSF1R Alone or in Combination with PD1 in Experimental Glioma
Justyna M Przystal, Hannes Becker, Denis Canjuga, et al.
Mabs
|
March 18, 2016
XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer
Juergen M Schanzer, Katharina Wartha, Ekkehard Moessner, et al.
The Journal of Experimental Medicine
|
February 14, 2018
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
Sabine Hoves, Chia-Huey Ooi, Carsten Wolter, et al.
Page
of 6